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Assessing  old-age  long-term  care  using  the  concepts  of 
healthy life expectancy and care duration: the new parameter 
“Long-Term Care-Free Life-Expectancy (LTCF)” 
 
 








Achieving old ages is also connected with prevalence of illness and long-term 
care. With the introduction of the statutory long-term care insurance in 1996 
and  the  long-term  care  statistics  in  1999  research  data  of  about 2.3  million 
people receiving long-term care benefits is available. Average life expectancy 
can be qualitatively divided into lifetime spent in good health and lifetime spent 
in long-term care dependence (average care duration). In Germany women’s 
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Introduction 
Life expectancy has been steadily rising owing to a wide variety of factors. As a 
result,  an  increasing  number  of  people  are  reaching  higher  ages  and  the 
channels through which these gains in age are made are different. An analysis 
of  mortality  development  opens  up  the  need  to  make  a  distinction  between 
qualitative and quantitative gains in life-expectancy growth. To understand and 
influence the mechanisms of life time extension, it is necessary to look at the 
determining factors in the context of the process of life span extension.  
 
A concept aimed at structuring lifetime is based on the consideration that every 
person eventually will die from an illness and that any preceding period of ill 
health  resulting  in  impairment  is  taken  into  account.  Total  lifetime  can  be 
divided  into  healthy  periods  and  periods  of  health  impairment  (concept  of 
healthy  life-expectancy).  It  can  be  safely  assumed  that  health  impairment 
increases with age. The effects of impairment, however, can be compensated 
or arrested by favorable social conditions. Medical progress such as advances 
in  prevention,  diagnostics,  curative  medical  care,  and  improvements  in  the 
availability and quality of medical aids potentially extends lifetime spent without 
impairment. The perception and assessment of one's own state of health is 
subject  to  age-dependent  changes  in  that  assessment.  Some  health 
impairments can be fully compensated so that they are not perceived as such. 
Good  access  to  medical  care,  high  levels  of  social  conditions,  and  the 
availability of emergency and non-emergency medical care produce extended 
periods of lifetime spent without impairment. These processes are overlapped 
by  social-class  affiliation  and  the  level  of  education.  Thus  it  is  important  to 
describe the above process in the context of the life-lengthening process.  
 
Many  international  studies  have  focused  on  healthy  life  expectancy.  They 
provide  evidence  for  an  increase  in  healthy  life  expectancy  over  the  last 
decades  (Cambois,  Robine  and  Hayward  2001,  Robine  and  Ritchie  1991, 
Doblhammer  and  Kytir  2001).  According  to  Cambois,  Robine  and  Hayward 
(2001),  and  Doblhammer  and  Kytir  (2001),  the  proportion  of  years  spent  in 
good  health  has  also  been  rising,  confirming  the  'compression  of  morbidity' 
hypothesis  espoused  by  Fries  (1989).  Certain  groups  differ  in  healthy  life   3 
expectancy  as,  according  to  Robine  and  Ritchie  (1991),  social  class 
differentials  are  larger  than  gender  differentials,  for  instance.  Crimmins  and 
Saito (2001) show that the development of healthy life expectancy differs for 
various educational groups. Compression of morbidity is seen notably among 
individuals who have enjoyed a high level of education. The poorly educated, 
by contrast, see morbidity expansion.  
 
Several studies have focused on the development of healthy life expectancy in 
Germany  (Brückner  1997,  Klein  and  Unger  1999,  Ziegler  and  Doblhammer 
2005, Gärtner and Scholz 2005). In most of them, survey data were used to 
apply various methods to compute healthy life expectancy. It turns out that life 
expectancy as such as well as healthy life expectancy is higher for women than 
it is for men. In terms of total life expectancy, however, men enjoy a larger 
share  of  years  spent  in  good  health  than  their  female  counterparts.  Bickel 
(2001) arrived at the same conclusion, having used German long-term care 
statistics  in  his  calculations  of  years  spent  without  long-term  care  (LTC) 
dependency.   
 
The study draws on statistics on the prevalence of statutory LTC in Germany to 
derive a parameter that links increased survival with care duration. As ill health 
and  accidents  resulting  in  LTC  may  occur  during  the  entire  life-course,  the 
parameter needs to be adjusted for age so that it refers to  "care in old age“. 
The parameter then corresponds to the statistical likelihood of care incidence. 
Up to age 60, the age-specific share of individuals receiving LTC benefits is 
less than 1% in Germany. When age 60+ is selected, a total of 22.6% of men 
and 9.2% of women are excluded in 2005. In this chapter, only LTC cases at 
age 60 and above are included in the calculations. The following parameters, 
applied to a standard population, are used: incidence of LTC; care duration, the 
number  of  LTC  beneficiaries.  This  system  has  the  advantage  that  it  is 
standardized,  comparable,  and  takes  into  account  the  process  of  longevity 
expansion.  
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An overview of the methodological implementations of Healthy Life Expectancy 
(HLE)  was  drawn  when  the  concept  was  devised.  Other  parameters  were 
developed in analogue (see Table 1). 
 
Table 1: 
Overview  of  measures  used  by  the  Sullivan  method  to  compute  health 
indicators to split life expectancy  




self-perceived health status, rated 
"very good" to "very poor" 
 








types of disability, e.g., hearing, 
speaking, visual disability, mental, 
physical or mental disability 
 
Sullivan 1971; Saito 







ADL limitations in bathing, 
dressing, toileting, continence, 
feeding 
 


























in receipt of LTC 
 
 












An advantage in using LTC statistics is that decisions reached on entitlement to 
LTC  benefits  follow  an  objective  procedure.  Further,  the  insurance  is 
mandatory, resting on the principles of solidarity. Independent of age, gender, 
and  insurance  contributions  the  scheme  grants  partially  comprehensive 
benefits on the basis of co-payment. With the enactment of statutory long-term 
care  insurance  in  Germany  and  the  introduction  of  corresponding  statistics 
based  on  a  complete  survey  of  LTC  benefits  received,  the  corresponding 
parameters  can  be  computed  for  the  whole  population,  using  the  Sullivan   5 
method. LTC benefits fall into three categories (home care benefits, institutional 
or nursing home benefits, or cash allowances) and three care-levels; these are 
determined  by  the  severity  of  impairment.  The  analysis  in  this  chapter, 
however, is limited to LTC benefits received, i.e. without restrictions by category 
and level. 
The  decision  to  introduce  LTC  statistics  was  taken  with  the  enactment  of 
statutory  long-term  care  insurance  in  1996  in  Germany.  A  universal  census 
collects data of all individuals receiving LTC benefits (with the effective date 
having been 15.12.1999 and from then onwards every two years). A decision 
on  LTC  provision  (or:  the  granting  of  LTC  benefits)  is  made  following  an 
objective  procedure  of  application  and  screening  by  the  medical  services 
(Medizinischer Dienst der Krankenversicherung, MDK) in accordance to strict 
statutory regulations  as laid down in § 18 of the German Social Code XI (SGB 
XI,  www.mdk.de). The quality of the statistics is high.  
 
Material and methods 
The data used for the purpose of analysis are drawn from the life tables on 
Germany and corresponding population data by age of the Human Mortality 
Database (www.mortality.org). The latter data were adjusted for age group 90+, 
thus evening out the population overestimation in the official statistics (Scholz 
and Jdanov 2007). To calculate the LTC rates, the LTC statistics by age and 
gender  were  analyzed.  These  are  accessible  through  the  Research  Data 
Centers of the Federal Statistical Office and the statistical offices of the Länder 
(www.forschungsdatenzentrum.de). By linking LTC cases with the population 
data, the LTC rates can be computed by age and gender. The multiplication of 
the LTC rates by the life table population of the given calendar year produces 
the  number  of  LTC  cases.  These  are  standardized,  independent  of  the 
population age-structure, and form part of the life table population. Accordingly, 
in the life table all lived years are divided into years spent in LTC and years 
without  LTC  (LTCF).  The  following  applies:  The  sum  of  the  total  life-table 
population is divided into LTC beneficiaries and individuals who do not receive 
LTC. Thus it is possible to look at the corresponding years spent in LTC and to 
compute  the  corresponding  periods  in  care.  The  corresponding  parameter 
denotes the care duration.    6 
The following applies:  




A comparison of the survival curves (between the life table l(x)  and the l(x) 
LTCF) is made in Figure 1. 
 
Figure 1: 
Survival  curve  of  life  table  l(x),  Long-Term  Care-Free  l(x)  (l(x)  LTCF)  and 
prevalence of LTC cases, Germany 2005 (Source: Calculations based on care 
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The  gap  between  the  two  survival  curves  shows  the  number  of  individuals 
drawing  LTC  benefits.  Only  LTC  cases  at  age  60+  are  considered.  The 
computation  of  the  parameter  produces  independent  and  adjusted  variables 
that  are  independent  of  the  age  structure  of  the  real  population  and  that 
correlate to the life-table population. Of interest are the areas below the curves 
(Figure 2), corresponding to life expectancy and care duration. Figure 2 shows 
differentials  by  gender  and  age.  The  LTC  beneficiaries  form  part  of  the 
population at a higher age.    7 
 
Figure 2:  
Standardized life-table population l(x) by age and gender based on an initial 
sample of 100 000 persons and persons 60+ receiving LTC benefits; Germany 




Division  of  life  expectancy  (LE)  into  Long-Term  Care-Free  Life  Expectancy 
(LTCF) and lifetime spent in care (LE - LTCF) 1999 and 2005 by gender, in 
absolute  years  and  relative  percent;  LTC  at  age  60+  (Source:  Calculations 
based on care statistics and HMD). 
measure  gender  1999  2005  changes  changes 
    in years  in years  in years  in % 
LTCF  women  77.58  78.48  0.91  1.2 
LTCF  men  73.01  74.67  1.66  2.3 
LE – LTCF  women  3.26  3.61  0.35  10.7 
LE - LTCF  men  1.75  2.05  0.30  16.9 
LE  women  80.84  82.10  1.26  1.6 
LE  men  74.76  76.72  1.95  2.6 
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Table 2 shows the quantification of the areas below the curves. The result is 
the division of life expectancy (LE) into lifetime spent in good health (LTCF) and 
lifetime spent in LCT dependence (LE - LTCF)). The differences in the values 
between 1990 and 2005 by year and percentage reflect the changes over time. 
The table reveals an increase in life expectancy owing to lifetime extension with 
as well as without LTC-dependence. The largest increases in absolute terms 
arise from dependency-free years for both genders. The relative increase is 
especially  high  for  care-duration.  Figure  3  compares  the  trends  in  life 
expectancy (LE) and healthy lifetime. It turns out that the increase in lifetime 
spent  without  LTC-dependence  is  almost  equal  to  the  increase  in  total  life 
expectancy. The relative trend in life expectancy (LE),  in lifetime spent in good 
health (LTCF) and lifetime spent in LTC dependence for both genders and for 
1999 (1999=100)) shows that the development for men is especially dynamic 
(see Figure 4). All of the three parameters show a reduction in the difference 
between men and women.  
A  closer  look  at  care  duration  (LE  -  LTCF)  (see  Table  3)  reveals  a  longer 
duration for women and a steady increase in care duration for both genders. 
Over  time,  care-duration  for  men  increases  more  steeply.  The  age-specific 
trend (see Figure 5) reveals stable age-specific patterns, possibly arising from 
differential selection of health risk by age. The higher the age, the longer the 
care duration. The only exceptions are age group 85+, especially women.  
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Figure 3: 
Trend  in  life  expectancy  (LE)  and  of  Long-Term  Care-Free  Life  Expectancy 
(LTCF) 1999 - 2005 by gender; LTC at age 60+ (Source: Calculations based on 
















Care  duration  (LE-LTCF)  in  years  by  gender;  LTC  at  age  60+  (Source: 
Calculations based on care statistics and HMD). 
 
  1999  2001  2003  2005 
women  3.26  3.43  3.38  3.61 
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Figure 4: 
Trend in life expectancy (LE), of Long-Term Care-Free Life Expectancy (LTCF) 
and  lifetime spent in care, 1999 - 2005, by gender, relative 1999=100; LTC at 
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Trend in care duration (LE-LTCF) by age group and gender; LTC at age 60+ 
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Conclusion 
The  analog  computation  of  the  real  population  in  Germany  produces 
parameters that are influenced by the age structure of the population. These 
parameters cannot be estimated owing to historical and epochal effects on the 
population structure. The division of life expectancy (LE) by person-years into 
LTC  dependency-free  years  (LTCF),  using  the  Sullivan  method,  and  years 
spent  in  LTC  (LE  -  LTCF)  produces  an  estimate  of  the  number  of  LTC 
beneficiaries and of the care duration. The focus on care at age 60+ produces 
specific care durations at old age. The following can be said: Care duration 
rises over time; the increase in LTC dependency-free periods (LTCF) is larger 
than extensions in care duration; care duration is longer among women than it 
is among men. Further, the increase in care duration by age reveals that health 
selection  in  terms  of  care  and  mortality  is  at  work.  The  results  largely 
correspond with the compression hypothesis.  
 
The calculation of life-expectancy parameters should be standardized within the 
framework  of  German  Federal  Health  Monitoring  (Gesundheitsbericht-
erstattung,  GBE).  The  age-specific  references  produce  different  long-term 
parameters.  Large  regional  differentials  in  the  parameter  "Long-Term  Care-
Free Life Expectancy (LTCF)“ point to differences in the quality of  long-term 
care provided and to the need for further action in Germany.  
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